Navigation Links
Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility

nd process development. It is a comprehensive, pan Wales programme, from the Welsh Assembly Government that provides easy access to funding and a unique range of skills and expertise. SMARTCymru has been developed in consultation with industry, with the specific aim of encouraging and supporting innovators to carry out R&D that has real commercial potential. Support is available for all phases of the development life-cycle, from feasibility to exploitation. It is open to all innovators who aim to create and exploit technologically innovative products and processes, based in Wales.

www.wda.co.uk/smartcymru

About VASTox plc

VASTox is a leading UK biotechnology company that discovers and develops proprietary new drugs. The Company's internal drug development programmes are underpinned by its advanced chemistry and drug screening (chemical genomics) technology platforms, which it also provides on a collaborative or fee-for-service basis to the pharmaceutical industry.

VASTox has a broad range of drug discovery programmes in the clinical, pre-clinical and discovery stages of development, which target serious diseases with a high unmet medical need. These therapeutic areas include neuro-disorders (neurodegenerative and neuromuscular), anti-infectives, ophthalmic diseases, oncology and regenerative medicines.

VASTox's in-house drug development capabilities combine world-class expertise in both medicinal and carbohydrate chemistry with high-volume, high-content screening using its proprietary zebrafish and fruitfly technologies (chemical genomics). These whole organism screens have the potential to dramatically decrease the time and cost of drug discovery and development by delivering data that are highly predictive of the efficacy and toxicity of potential drug compounds in humans.

The company listed on the AIM market of the London Stock Exchange in October 2004 - s
'"/>




Page: 1 2 3

Related medicine technology :

1. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
2. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
3. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. President Bush Ignores Americas Plea for Support of Stem Cell Research
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
11. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
Post Your Comments:
(Date:1/6/2009)...BRIDGE, Mass., Jan. 6 Cequent Phar... products to deliver RNAi-based treatments to prev...mpany has recently completed a successful toxicolo...stered tk RNAi therapeutic targeting the primary ...denomatous polyposis). FAP is an inherited gastroi...
(Date:1/5/2009)... SAN JOSE, Calif., Jan. 5 Women un...gesterone medication to help support early,pregna...ms of this medication,can be painful for patients...can be administered by subcutaneous injection or v... better patient tolerance. , With patient w...
(Date:12/27/2008)... SAN DIMAS, Calif., Dec. 27 Accord... are best advised to consume modest doses of,resv...typically provided in 3,to 5 glasses of aged, red...oto: http://www.newscom.com/cgi-bin/prnh/2008060...mega-dose resveratrol alone fails to prolong,the ...
(Date:12/17/2008)...TO, Calif., Dec. 17 PEAK Surgical,...d a new tissue dissection system based on a,propr...ood and Drug,Administration (FDA) has granted the...urgery System for cutting and coagulation of soft ...r, nose and throat), gynecologic,orthopedic, art...
Breaking Medicine Technology:Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 1EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 2EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 3Concentric Medical 28R 29 Announces Co Marketing Agreement With InTouch Health 28R 29 to Advance Acute Ischemic Stroke Care 7088 1Concentric Medical 28R 29 Announces Co Marketing Agreement With InTouch Health 28R 29 to Advance Acute Ischemic Stroke Care 7088 2MabVax Therapeutics Closes Two Licensing Agreements With Sloan Kettering Institute for Cancer Research 2820 1MabVax Therapeutics Closes Two Licensing Agreements With Sloan Kettering Institute for Cancer Research 2820 2Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 1Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 2Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 3
...ering-Plough Announces Presentation Of Phase II Tr...onist At The 2007 Annual,Meeting Of The American C...March 16, 2007 /PRNewswire-FirstCall/ --,Schering-... the,Phase II trial of its novel oral thrombin rec...d at the 2007 annual Scientific Sessions,of the of...
...N CARLOS, Calif., March 19, 2007 /PRNewswire-First...l data from the ANTHEM,(Anticoagulation with rNAPc...oking at recombinant nematode anticoagulant protei...ute coronary syndromes,(NSTE-ACS) will be presente...(ACC) 56th Annual Scientific Session taking place ...
Other Medicine Technology:Media Advisory: ACC Updated Schedule 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:1/8/2009)..., Board Decision May Be Revealed Friday, January...re/ -- Today, Service Employees International Uni...ce call of the SEIU International Executive Board ...ome and homecare members out of SEIU United Health...te, but delayed the final decision until tomorrow....
(Date:1/8/2009)..., New Allscripts Prenatal Solution Key Factor in ... CHICAGO and ORLANDO, Fla., Jan. 8 /PRNewswire-Fir...an Associates LLC, one of the largest multi-specia..., has selected the Allscripts Enterprise(TM) Elect...their 80 physicians in 18 offices across Central F...
(Date:1/8/2009)..., BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -...pleased to announce that throughout the fourth qua..., Orthotics Center, Rocky Mountain Orthotic-Prosth...Services, Inc., First Coast Orthotics & Prosth.... These acquisitions add patient care centers to e...
(Date:1/8/2009)..., WASHINGTON, Jan. 8 T... D. Olson has been named director, chemical and fo...ices Policy program. Olson, who was formerly deput... Committee on Environment and Public Works, brings...licy and consumer advocacy to Pew. , , "We are...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2
...of Texas Health Center at Tyler has discovered how...ocess works. Once the process// is thoroughly unde...ulate it, thus preventing excessive bleeding or bl...er, Ph.D., and his team are published in the Aug. ...
...ive up smoking may be more successful than anyone ... to a new study in the July-August 2006// Nursing ... nurses are widely recognized as central to global... of tobacco use," said Dr. Molly C. Dougherty, Nur...
...accepted as a hazard of aging, but researchers act...es are a consequence of aging// or not. Researcher... the Scripps Research Institute have now conducted...is critical for diseases like Alzheimer's. Harmfu...
...mu and Kashmir is having a severe impact on the me...ildren.// More and more women are knocking on th...fe-torn state. Over 50 percent of some 60,000 peop... mental disorders in the past decade have been wom...
Other Medicine News:Health News:Scientist Discovers Crucial Part of Blood-Clotting Process 2Health News:Nurses Can Play Big Role In Helping Patients Quit Smoking 2Health News:Aging Critical For Alzheimer's Disease 2Health News:Aging Critical For Alzheimer's Disease 3Health News:More People Seeking Treatment for Mental Illness in Strife-torn Kashmir 2
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: